Health Catalyst, Inc. Cash Flow Statement
HCAT|7 years of annual SEC 10-K data (FY2019-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 7 fiscal years. All figures from audited SEC 10-K filings.
Health Catalyst, Inc. used $33M in operating cash flow and negative free cash flow of $34M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income | -$118.1M | -$137.4M | -$153.2M | -$115.0M | -$60.1M | -$62.0M | -$47.0M |
| Depreciation & Amortization | $42.2M | $48.3M | $37.5M | $18.7M | $9.2M | $7.4M | $5.9M |
| Operating Cash Flow | -$33.1M | -$35.3M | -$23.1M | -$26.1M | -$32.2M | -$40.3M | -$36.8M |
| Capital Expenditures | $1.2M | $2.2M | $10.4M | $7.8M | $2.0M | $2.1M | $2.5M |
| Free Cash Flow | -$34.3M | -$37.4M | -$33.6M | -$33.9M | -$34.2M | -$42.4M | -$39.3M |
| Share Buybacks | $1.8M | $8.4M | $0 | $0 | - | $8.7M | $0 |
| FCF Margin | -11.6% | -13.6% | -13.9% | -18.0% | -22.1% | -37.6% | -53.8% |